JeNaCell GmbH, a Jena, Germany-based maker of a high-performance biomaterial for applications in medicine, cosmetics, and technology, has raised €700k in seed funding.
Backers include High-Tech Gründerfonds and STIFT.
The company plans to use the capital for optimizing the products, building up an automated production facility, as well as preparatory measures for the market introduction of the high-tech biomaterial.
A spin-off of the Friedrich Schiller University in Jena, and led by Dr. Nadine Hessler, CEO, JeNaCell is based on a new and patented process for the continuous production of a high-performance biomaterial with natural nanostructures, which can be used for making innovative medical and cosmetic products.
FinSMEs
12/10/2012